28 www.labmedonline.org eISSN 2093-6338 rea but also globally. New-onset or recurrent stroke is diagnosed in ~105,000 patients in Korea every year, and more than 26,000 patients die due to this condition [1]. In fact, after cancer, stroke is the second leading cause of death worldwide, resulting in an annual mortality rate of 53.2 per 100,000 in 2010 [1].High-sensitivity cardiac troponin T and I (cTnT and cTnI) levels have been well-documented as sensitive and speci c biomarkers of myocardial necrosis [2]. Recently, elevated cardiac troponin levels were reported not only in patients with ischemic myocardial damage but also in those with acute ischemic stroke [3,4]. The causes of elevated cTnT levels and the mechanisms by which cTnT is elevated in patients with acute ischemic stroke are variable and the clinical signi cance is still unclear [3,4].In some studies, an elevated cTnT level was a predictor of poor clinical outcomes and higher mortality in patients with acute ischemic stroke [5][6][7]. In contrast, other studies have reported that an Background: Elevated cardiac troponin T (cTnT) levels have been reported in patients with acute ischemic stroke, however, the prognostic relevance is not well established. We evaluated the association between cTnT elevation and prognosis in patients with acute ischemic stroke. Methods: The 182 consecutive patients enrolled had new-onset acute ischemic stroke. Their clinical and laboratory findings were collected retrospectively. Stroke severity and prognosis were determined using the National Institutes of Health Stroke Scale (NIHSS) and the modified Rankin Scale (mRS) scores, as well as 30-day all-cause mortality. The patients were divided into two groups according to their cTnT levels: ≤ 14 and >14 ng/L. Cox proportional hazards regression analysis was performed to determine the associations between clinical or laboratory variables and 30-day all-cause mortality. The Kaplan-Meier method was used to compare the overall survival rate in patients with elevated and normal cTnT levels. Results: The cTnT level was elevated in 14.8% of the patients. Age, NIHSS and mRS scores, creatinine kinase-MB, and 30-day all-cause mortality were significantly higher in patients with elevated cTnT levels than in those with normal cTnT levels. The hazard ratio of the elevated vs. normal cTnT group for 30-day all-cause mortality was 8.06 (95% confidence interval: 1.13-57.25, P =0.037). A Kaplan-Meier survival analysis revealed a significantly higher survival rate in patients with normal cTnT levels compared to those with elevated cTnT levels (P < 0.0001). Conclusions: An elevated cTnT level is significantly associated with poor short-term outcomes in patients with acute ischemic stroke.